Extrachromosomal DNA (ecDNA) has been identified as a critical component of tumour evolution, offering a dynamic genetic and regulatory landscape through which cancer cells can alter oncogene dosage, transcriptional states, and cellular phenotypes. Lacking centromeric and telomeric sequences, ecDNA is inherited in a no...
Verity Ghansah, Yemisi Omotoyosi Adetayo, Oluwabukunmi M. Oluwaniran et al.· Oncology, Nuclear Medicine a...· 0 citations
CRISPR-Cas9 has demonstrated considerable clinical potential across a range of therapeutic applications, particularly for selected monogenic disorders in which the strongest clinical evidence is currently available.
M. D. Badru, Verity Ghansah, Ifeoluwa Oyinkansola Adesanya et al.· Australian Journal of Biomed...· 0 citations
Current evidence supports separate translational pathways in SCD and malaria applications remaining predominantly preclinical, with clinical progress established in SCD and malaria applications remaining predominantly preclinical.
Comfort Ohunene Matthew, B. Inyang, Verity Ghansah et al.· Epidemiology and Health Data...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.